US oil firms trying to get into Venezuela are reportedly facing difficulties, WSJ reports citing sources
Newsquawk Staff ·
- ExxonMobil (XOM), Chevron (CVX) and other major oil companies are reportedly vying for a small number of Venezuela's most attractive drilling spots, but some of the talks with Venezuelan leaders recently hit an impasse.
What it means
Attempts by US majors to re-enter Venezuela follow a familiar sequence: sanctions relief or licensing opens the door politically, negotiations then stall on the commercial terms, with contract sanctity, debt recovery, and operational control the recurring sticking points rather than geology. Prior episodes of re-entry into resource-rich states with a history of expropriation have tended to resolve slowly, and companies with legacy claims and existing in-country infrastructure have historically held the advantage over those seeking new positions. The relevant distinction is between firms negotiating for incremental output from existing ventures and those bidding for fresh acreage, since only the former has a near-term path to barrels. Talks hitting an impasse at this stage is the norm rather than the signal; what has mattered in comparable episodes is whether the host government softens terms under fiscal pressure or whether Washington re-tightens the licensing regime, either of which resets the table. For crude balances, Venezuelan supply additions from any such deal have tended to arrive over years, not quarters, so the read-through to prompt spreads is limited. The follow-ons are any shift in sanctions licensing and whether individual companies disclose progress or writedowns around their legacy claims.
Sources
- US FDA approves subcutaneous induction regimen for AbbVie’s (ABBV) Skyrizi for adults with moderately to severely active Crohn’s disease
- Kimi K3.1 Pro AI model builds GTA VI-style (TTWO) playable game demo in just 10 hours for USD 52, developer claims on X; showcases AI’s ability to generate video game experiences - UNCONFIRMED
- OpenAI expects future AI models to be capable of identifying and exploiting vulnerabilities that are currently unknown, according to a blog post
- Texas Attorney General Ken Paxton sues OpenAI and CEO Sam Altman for lying to users and harming Texans
- Daily US Earnings Estimates: 26th October 2026: VZ, WELL
Related headlines
- Moonshot AI unveils 2.8tln-parameter Kimi K3.1 Pro model; says it beats Opus 5.5 and GPT-6 Astra on long-horizon coding tasks and scores top marks on SWE Marathon and agent benchmarks; pledges open weights for the 3tln-class model by November 4th2 hours ago
- The Trump administration plans to introduce voluntary “US Caught Seafood” labels to help consumers identify seafood origins, according to CBS3 hours ago
- Bristol Myers Squibb (BMY) spokesperson says the company has identified the cause of an earlier Car-T safety signal; will look to resume the paused trials in 20273 hours ago
- OpenAI reveals plans for an in-house exabyte-scale storage system3 hours ago
- Republican Senator Blackburn has raised concerns about Meta’s (META) plans to update its commercial terms, warning that the changes could “exploit American creators and businesses,” according to a letter3 hours ago
- Upside in Penguin Solutions (PEGN) attributed to M&A chatter - UNCONFIRMED 4 hours ago
- CrowdStrike (CRWD) CEO says in the coming months we will see a lot of breaches from the PHP vulnerability4 hours ago
- US President Trump says Elon Musk will not do anything wrong regarding access to Starlink (SPCX) in Ukraine4 hours ago
- CNBC speculates that Verizon (VZ) would most likely be involved in the context of a partnership with SpaceX (SPCX)5 hours ago
- Ukraine President Zelensky says the Tesla (TSLA)/SpaceX (SPCX) Starlink and Starshield service remains slowed5 hours ago
- US EQUITY OPEN: Breadth poor at the open: Energy leads gains on oil rally, Tech sees slight bounce5 hours ago
- Meta (META) says it will extend the implementation date of updated commercial terms to November 20th (prev. October 30th); extension will allow it to explain the changes to partners and stakeholders6 hours ago
- Abbott (ABT) presents new ESMO data showing 30% absolute improvement in sensitivity with the whole-genome sequencing Oncodetect test in colorectal cancer6 hours ago
- Daily US Equity Opening News: SPCX explores access to 80K US cell sites; OpenAI nears USD 30bln funding at $1.25T valuation6 hours ago
- American Express (AXP) to cut 5% of jobs7 hours ago